STRS Ohio’s 10x Genomics TXG Stock Holding History

STRS Ohio’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.02M	Sell	48,100 -4,500	-9%	-$90K	﹤0.01%	708
2025 Q4	$858K	Sell	52,600 -6,500	-11%	-$98.2K	﹤0.01%	755
2025 Q3	$691K	Sell	59,100 -3,500	-6%	-$45.6K	﹤0.01%	845
2025 Q2	$725K	Buy	+62,600	New	+$571K	﹤0.01%	1040
2023 Q4	–	Sell	-13,789	Closed	-$568K	–	2014
2023 Q3	$568K	Buy	13,789 +1,986	+17%	+$103K	﹤0.01%	1177
2023 Q2	$659K	Buy	+11,803	New	+$639K	﹤0.01%	1115
2022 Q2	–	Sell	-719	Closed	-$54K	–	2297
2022 Q1	$54K	Hold	719	–	–	﹤0.01%	1933
2021 Q4	$107K	Hold	719	–	–	﹤0.01%	1886
2021 Q3	$104K	Hold	719	–	–	﹤0.01%	1936
2021 Q2	$140K	Sell	719 -6,172	-90%	-$1.12M	﹤0.01%	1902
2021 Q1	$1.25M	Buy	6,891 +255	+4%	+$44K	﹤0.01%	1011
2020 Q4	$939K	Buy	6,636 +316	+5%	+$45.9K	﹤0.01%	1103
2020 Q3	$787K	Buy	+6,320	New	+$663K	﹤0.01%	1062

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

STRS Ohio's TXG Position: Q1 2026 in Review

STRS Ohio reduced its 10x Genomics (TXG) stake by 8.6% in Q1 2026, selling an estimated $90K and leaving 48,100 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #708.

STRS Ohio first reported a position in TXG in Q3 2020 and has held it in 13 quarters since. The position peaked at $1.25M in Q1 2021. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

STRS Ohio held 48,100 shares of 10x Genomics worth $1.02M as of Q1 2026.
STRS Ohio sold 4,500 10x Genomics shares in Q1 2026, an estimated $90K.
10x Genomics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #708 holding.
STRS Ohio first reported a position in 10x Genomics in Q3 2020 and has held it in 13 quarters since.
STRS Ohio's 10x Genomics position peaked at $1.25M in Q1 2021.
329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.